{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:40Z","timestamp":1792215820218,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clinre.2026.102895","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:31:27Z","timestamp":1785281487000},"page":"102895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical applications of anti-centromere antibody in primary biliary cholangitis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5044-0421","authenticated-orcid":false,"given":"Song","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ping","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102895_bib0001","article-title":"Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: a real-world retrospective study of 537 patients in China","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102895_bib0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12876-023-02859-4","article-title":"Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sj\u00f6gren's syndrome: a retrospective study","volume":"23","author":"Gao","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102895_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2026.102846","article-title":"Clinical features of anti-gp210-positive, AMA-negative patients with abnormal liver function","volume":"50","author":"Ma","year":"2026","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102895_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2026.100366","article-title":"Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis","volume":"12","author":"Antal-Szalm\u00e1s","year":"2026","journal-title":"J Transl Autoimmun"},{"issue":"8","key":"10.1016\/j.clinre.2026.102895_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/00365513.2025.2598748","article-title":"Quantitative detection of anti-centromere antibodies in primary biliary cholangitis: value of chemiluminescence immunoassay","volume":"85","author":"Jin","year":"2025","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.clinre.2026.102895_bib0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2026.102895_bib0007","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.dld.2024.12.024","article-title":"The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: enhancing the prognostic utility on the GLOBE scoring system","volume":"57","author":"Ding","year":"2025","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.clinre.2026.102895_bib0008","first-page":"224","article-title":"[Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria]","volume":"34","author":"Luo","year":"2026","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"8","key":"10.1016\/j.clinre.2026.102895_bib0009","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol Res"},{"issue":"22","key":"10.1016\/j.clinre.2026.102895_bib0010","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.3390\/jcm12227047","article-title":"Primary biliary cholangitis (PBC)-autoimmune Hepatitis (AIH) Variant syndrome: clinical features, response to therapy and long-term outcome","volume":"12","author":"Graf","year":"2023","journal-title":"J Clin Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:17:55Z","timestamp":1792214275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2210740126001415"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102895","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical applications of anti-centromere antibody in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102895"}}